Express delivery
All orders are shipped with Econt
Cash on delivery
Reliable and convenient payment methods
Proven quality
Peptides tested at Janoshik Labs
Express delivery in 1-3 business days.
Each peptide comes with bacteriostatic water.
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide originally discovered in mammalian brain tissue in the 1970s. It is an octopeptide that has been studied in the scientific literature for its role in sleep regulation, stress response, and neuroendocrine balance. In research settings, DSIP has been studied as a modulator of homeostatic processes related to sleep, cortisol levels, and adaptation to psychophysiological stress.
In preclinical and clinical studies, DSIP has been the subject of interest for its potential ability to promote deep (slow-wave) sleep, stabilize circadian rhythms, and reduce excess cortisol secretion. Some studies have also considered DSIP as a co-regulator of other neurohormones - somatotropin, prolactin, and ACTH - in the body's adaptation to exertion, fatigue, and chronic stress.
In the scientific literature, DSIP has been studied for its possible role in:
Improves sleep quality - helps enter deep sleep and stabilizes circadian rhythms
Regulation of cortisol levels - potential effect on stress response and homeostasis
Supports neuroendocrine function - balances the secretion of hormones involved in sleep and adaptation
Neuroprotection - potential antioxidant and anti-stress effect on the central nervous system
Stimulation of recovery processes - studied in cases of physical and mental fatigue
Mood modulation - some studies discuss involvement in serotonergic regulation
DSIP has been studied in various fields - neuroscience, psychoneuroendocrinology, sports physiology, and gerontology.
In sleep studies, an increase in deep phases (NREM) and better sleep quality have been observed
In models of stress and fatigue, a reduction in cortisol and improvement in recovery performance are reported.
Under chronic stress, DSIP has been studied for its effect on neuroendocrine balance and adaptation.
In neurology, its potential neuroprotective function against oxidative stress is being examined.
In sports medicine, it is analyzed as a factor for faster recovery in the absence of sufficient sleep.
The scientific literature describes subcutaneous administration once daily at 100-300 μg daily, usually in the evening before bedtime. It is used to study neuroendocrine mechanisms, with no approved therapeutic dose.
At 5 mg + 3 ml bacteriostatic water:
Concentration = 1.67 mg/ml → 0.06 ml = 100 μg
Example values:
0.06 ml = 100 μg
0.12 ml = 200 μg
0.18 ml = 300 μg
0.24 ml = 400 μg
0.3 ml = 500 μg
DSIP is not intended for use in sports, but it is being investigated in the scientific literature for its potential role in adaptation to exercise and sleep regulation in highly trained individuals. Due to its possible effects on cortisol and recovery, DSIP is included in the WADA list of peptides that are subject to control in professional athletes.
May help normalize sleep during intense training regimens
It is being studied as a possible factor for better adaptation to chronic fatigue.
Potential synergy with peptides regulating the GH/IGF-1 axis
In research settings, DSIP is generally well tolerated. The reported reactions are rare and dose-dependent:
Transient drowsiness or fatigue after administration
Mild dizziness or drop in blood pressure
Headache, hot flashes, or feeling relaxed
At higher doses, isolated cases of mild hypotension and decreased concentration have been observed due to the sedative effect.
The information is based on published scientific sources and is for educational purposes only. It is not intended to diagnose, treat, or prevent disease.